Skip to main content

Waters Corp(WAT-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low299.36
Day High307.00
Open:303.65
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

Top Stories: Waters Corp

Select a category then submit the form to load news
Tipranks
Waters Details Financial Impact of Recent SpinCo Acquisition
The Globe and Mail
13 U.S. health care stocks to consider in uncertain markets
For Number Cruncher column in Globe Investor/ROB only.
StockStory
Winners And Losers Of Q4: Waters Corporation (NYSE:WAT) Vs The Rest Of The Research Tools & Consumables Stocks
WAT
Newswire.ca
Waters Flagship ARES‑G3 Rheometer Sets New Benchmark for Data Quality at Breakthrough Speed
StockStory
3 Cash-Producing Stocks Walking a Fine Line
SAIA
StockStory
3 Reasons to Sell WAT and 1 Stock to Buy Instead
WAT
StockStory
3 Reasons to Avoid WAT and 1 Stock to Buy Instead
WAT
StockStory
1 S&P 500 Stock on Our Buy List and 2 We Ignore
WAT
Newswire.ca
Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage
StockStory
WAT Q4 Deep Dive: Acquisition Integrates BD Biosciences, Margin Pressures Offset Revenue Growth
WAT
Motley Fool
Waters (WAT) Q4 2025 Earnings Call Transcript
Tipranks
Waters (WAT) Receives a Hold from Wells Fargo
Tipranks
J.P. Morgan Keeps Their Hold Rating on Waters (WAT)
Tipranks
Analysts Offer Insights on Healthcare Companies: Personalis (PSNL), Waters (WAT) and Alkermes (ALKS)
Tipranks
Waters resumed with an In Line at Evercore ISI
Tipranks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Warby Parker (WRBY) and Waters (WAT)
Tipranks
Waters Corp Earnings Call: Growth, Risks and Synergies
Tipranks
Wall Street Analysts Are Bullish on Top Healthcare Picks
StockStory
Waters Corporation (NYSE:WAT) Reports Q4 CY2025 In Line With Expectations
WAT
Newswire.ca
Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses
Tipranks
Analysts Offer Insights on Healthcare Companies: Resmed (RMD), Waters (WAT) and Teva Pharmaceutical (TEVA)
StockStory
1 Profitable Stock on Our Buy List and 2 We Avoid
GM
Tipranks
Waters shareholders approve transformative BD business combination
Tipranks
Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK) and Waters (WAT)
Tipranks
Analysts Are Bullish on These Healthcare Stocks: Roche Holding AG (RHHVF), Waters (WAT)
Tipranks
Waters Issues Supplemental Disclosures to Keep Merger on Track
StockStory
3 Mid-Cap Stocks We Steer Clear Of
NCLH
Tipranks
Waters Highlights Investor Update and Spin-Off Transaction Progress
Tipranks
William Blair Initiates a Buy Rating on Waters (WAT)
Tipranks
TD Cowen Remains a Hold on Waters (WAT)
StockStory
3 Cash-Producing Stocks Walking a Fine Line
WW
StockStory
2 Unpopular Stocks That Deserve Some Love and 1 That Underwhelm
AIR

Profile

Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.